GlassScriptPhysician profile
Steven A Clark
NPI 1821292517
$2,420.55
in general payments reported to CMS, 2019-2025
21 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $8.26 · 2021: $33.81 · 2022: $251 · 2023: $265 · 2024: $310 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $792.11 | 2019-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Variax |
| Axogen | $302.65 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Abbvie INC. | $178.13 | 2025 | |
| Konica Minolta Healthcare Americas, INC | $160.36 | 2019 | |
| Allergan, INC. | $157.27 | 2019-2022 | |
| Tela Bio, INC. | $145.05 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novo Nordisk INC | $121.96 | 2024 | Wegovy, Ozempic |
| Pacira Pharmaceuticals Incorporated | $116.44 | 2019-2025 | Exparel |
| Sientra, INC. | $108.82 | 2019 | |
| Smith+Nephew, INC. | $70.19 | 2025 | Vlp Mini-Mod, Pico 7 |
| Orthofix Medical, INC. | $50.92 | 2023-2025 | Physio-Stim |
| Pylant Medical | $37.72 | 2019-2024 | |
| Sonex Health, INC. | $35.91 | 2024 | Sx-One Microknife |
| Davol INC. | $23.44 | 2022 | |
| Baxter Healthcare | $21.51 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocircuit Technologies INC | $20.68 | 2025 | Nerve Tape |
| Reprise Biomedical, INC. | $20.51 | 2022 | |
| Endo Pharmaceuticals INC. | $18.19 | 2021 | |
| Becton, Dickinson and Company | $15.62 | 2021 | |
| Galderma Laboratories, L.P. | $14.81 | 2022 | |
| Trice Medical, INC. | $8.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.